12-Month Lobbying Summary - In-house Corporation

• Subject matter details in previous versions

  Details Regarding the Identified Subject Matter

  Subject matters	Details	Categories
  Subject matters were not required to be associated with subject matter details when this content was submitted	Canada Agency for Drugs and Technologies in Health (CADTH) as it relates to health economics assessment and recommendations made on new medicines.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Federal Government First Nations and Inuit Health Branch program with respect to health services. Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution.	Legislative Proposal, Bill or Resolution, Regulation
  Subject matters were not required to be associated with subject matter details when this content was submitted	Policy and Programs Health Canada and Public Health Agency of Canada policies and programs to prevent and treat HIV and eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy and therapeutic efforts against the fight for COVID-19.	Policies or Program

  Subject matters in previous versions

  • Aboriginal Affairs
  • Economic Development
  • Federal-Provincial Relations
  • Health
  • Immigration
  • Industry
  • Intellectual Property
  • International Trade
  • Research and Development
  • Science and Technology

Government Institutions

• Canadian Institutes of Health Research (CIHR)
• Correctional Service of Canada (CSC)
• Finance Canada (FIN)
• Global Affairs Canada (GAC)
• Health Canada (HC)
• House of Commons
• Immigration, Refugees and Citizenship Canada (IRCC)
• Indigenous Services Canada (ISC)
• Innovation, Science and Economic Development Canada (ISED)
• Patented Medicine Prices Review Board (PMPRB)
• Privy Council Office (PCO)
• Public Health Agency of Canada (PHAC)
• Senate of Canada

Communication techniques

Communication techniques that have been used or are expected to be used in the course of the undertaking:

• Written communication
• Oral communication

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

• Bobby Sutherland, Sr. Director, Government Affairs | No public offices held